Direct Oral Anticoagulants for Rheumatic Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement
JACC: Clinical Electrophysiology · 2024-12 · 10 (12) · 2701-2710
DOI: 10.1016/j.jacep.2024.08.005 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift JACC: Clinical Electrophysiology, 2024-12. Verfasst von Ayman R Fath und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Texas Health Science Center, San Antonio, Texas, USA. Electronic address: aymanfath.md@gmail.com. Hauptthemen laut MEDLINE: Rheumatic Heart Disease, Atrial Fibrillation, Anticoagulants, Warfarin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, University of Texas Health Science Center, San Antonio, Texas, USA. Electronic address: aymanfath.md@gmail.com.
- Cardiology Department, Westchester Medical Center, New York Medical College, Valhalla, New York, USA.
- Department of Pharmacy, Practice and Science, College of Pharmacy University of Kentucky, Lexington, Kentucky, USA.
- Division of Cardiology, University of Texas Health Science Center, San Antonio, Texas, USA.
- Division of Cardiology, University of Texas Medical Branch, Galveston, Texas, USA.
- Lifespan Cardiovascular Institute, Providence, Rhode Island, USA; Department of Cardiology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Zitieren
APA
Fath, A. R., Aglan, A., Altaee, O., Fichardt, H., Mansoor, H., Almomani, A., Hammadah, M., Vinas, A., Nayak, H., Jneid, H., Saad, M., & Elgendy, I. Y. (2024). Direct Oral Anticoagulants for Rheumatic Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement. JACC: Clinical Electrophysiology, 10(12), 2701-2710. https://doi.org/10.1016/j.jacep.2024.08.005
Vancouver
Fath AR, Aglan A, Altaee O, Fichardt H, Mansoor H, Almomani A, et al. Direct Oral Anticoagulants for Rheumatic Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement. JACC: Clinical Electrophysiology. 2024;10(12):2701-2710. doi:10.1016/j.jacep.2024.08.005
BibTeX
@article{Fath2024,
author = {Fath, Ayman R and Aglan, Amro and Altaee, Osamah and Fichardt, Hendre and Mansoor, Hend and Almomani, Ahmed and Hammadah, Muhammad and Vinas, Ariel and Nayak, Hemal and Jneid, Hani and Saad, Marwan and Elgendy, Islam Y},
title = {Direct Oral Anticoagulants for Rheumatic Heart Disease-Associated Atrial Fibrillation Post-Bioprosthetic Mitral Valve Replacement},
journal = {JACC: Clinical Electrophysiology},
year = {2024},
volume = {10},
number = {12},
pages = {2701--2710},
doi = {10.1016/j.jacep.2024.08.005}
}
EUVIMED